JelloX Biotech Inc. is a startup company focusing on open innovation in translating 3D digital pathology imaging with AI-empowered analysis into precision diagnosis solution. Proprietary technologies enable 3D image-inspired AI models to facilitate spatial feature recognition and 3D pathology parameters including recent publication of lung cancer PD-L1 biomarker profiling for 3D TPS evaluation with better concordance to IO drug treatment outcome, and prostate cancer whole lumen morphology for 3D Gleason scoring with rapid process. We have developed perineural invasion AI model for oral cancer, and H&E image-based fluorescence nuclear detection AI model for breast cancer. JelloX 3D + AI solution is compatible with current pathology workflow allowing subsequent H&E, IHC, and genetic tests to establish an innovative Panoramic Pathology Platform in support of multidimensional tumor atlas analyses. Meanwhile, JelloX MetaLite software with CPU-based edge AI solution has become Intel Market Ready Solution for partnership in business development. JelloX digital pathology platform with federated learning (FL) modules is integrated with Roche Diagnostic system as a powerful AI+FL solution for smart hospital and modern reference lab in support of precision medicine and drug development. JelloX Biotech is now seeking for partnership to boost global market penetration and company valuation.
We're tracking JelloX Biotech Inc.'s market expansion
How JelloX Biotech Inc.'s international expansion compares to its competitors
JelloX Biotech Inc.YouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 JelloX Biotech Inc.You | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
JelloX Biotech unveils AI and 3D digital pathology vision for patient-centered cancer care, partnering with US medical institution.
JelloX Biotech unveils AI-powered 3D digital pathology vision for cancer care, partnering with major US medical institutions to improve patient outcomes using advanced technology.
JelloX Biotech unveils AI-driven 3D digital pathology vision for patient-centered care, collaborating globally to improve cancer diagnosis and treatment outcomes.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about JelloX Biotech Inc.'s business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
